Novel psychoactive substance use among treatment‐seeking opiate users: The role of life events and psychiatric symptoms

Abstract

Synthetic cathinones might still substitute amphetamine-derivatives, although these NPS are no longer legal. There is a need for the regular screening of psychiatric symptoms and the use of family therapy among participants on opioid substitution programs.